HeartFlow

HeartFlow is a pioneering medical technology company dedicated to revolutionizing precision heart care through advanced artificial intelligence and computational fluid dynamics. Founded in 2007, the company has developed a novel, non-invasive approach to diagnose and manage coronary artery disease (CAD). Their flagship technology creates a precise, three-dimensional, dynamic digital model of a patient's heart, enabling healthcare professionals to visualize blood flow and assess the impact of blockages. This AI-driven platform offers a best-in-class diagnostic solution, transforming cardiovascular care by providing actionable insights directly from standard CT angiography images. HeartFlow's mission is to improve patient outcomes and reduce healthcare costs by offering a more accurate and efficient diagnostic pathway. The company operates with an employee range of 500 - 1,000 individuals, fostering a culture of innovation and collaboration. Meet HeartFlow's team to understand the expertise driving these advancements. Their commitment to pushing the boundaries of medical technology is evident in their continuous development and strategic partnerships within the healthcare ecosystem. HeartFlow's financial performance is robust, with reported revenue of $191.4M. This financial strength supports their ongoing research and development efforts, allowing them to expand their reach and impact in the global market. Explore financial highlights for detailed performance metrics and investment history. The company's innovative solutions are critical for healthcare providers seeking to enhance diagnostic accuracy and patient management for cardiovascular conditions, positioning HeartFlow as a leader in digital health and AI-driven medical devices.